Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT)

Approximately 5% of patients with sarcoidosis have clinically manifest cardiac involvement. Clinical features of Cardiac Sarcoidosis are dependent on the location, extent, and activity of the disease. First line therapy is usually with prednisone and this is recommended based on clinician experience...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	The American heart journal Ročník 220; s. 246 - 252
Hlavní autoři:	Birnie, David, Beanlands, Rob S.B., Nery, Pablo, Aaron, Shawn D., Culver, Daniel A., DeKemp, Robert A., Gula, Lorne, Ha, Andrew, Healey, Jeffery S., Inoue, Yuko, Judson, Mark A., Juneau, Daniel, Kusano, Kengo, Quinn, Russell, Rivard, Lena, Toma, Mustafa, Varnava, Amanda, Wells, George, Wickremasinghe, Melissa, Kron, Jordana
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Elsevier Inc 01.02.2020 Elsevier Limited
Témata:	Arrhythmia Biomarkers Biomedical materials Cardiomyopathies - complications Cardiomyopathies - drug therapy Clinical trials Conduction Corticosteroids Diabetes mellitus Drug Administration Schedule Drug Therapy, Combination Equivalence Trials as Topic Fibrosis Glucocorticoids - administration & dosage Glucocorticoids - adverse effects Health risks Heart Humans Hypertension Immunomodulators Methotrexate Methotrexate - administration & dosage Multicenter Studies as Topic Osteoporosis Patients Perfusion Physicians Prednisone Prednisone - administration & dosage Prednisone - adverse effects Prospective Studies Quality of Life Randomization Randomized Controlled Trials as Topic Research Design Sarcoidosis Sarcoidosis - complications Sarcoidosis - drug therapy Side effects Steroid hormones Steroids Ventricle United Kingdom > UK Canada United States > US
ISSN:	0002-8703, 1097-6744, 1097-6744
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!